Diaphragmatic Ultrasonography in Difficult Weaning

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Weaning Mechanical Ventilation; ICU Ill Patients; Diaphragm Dysfunction Interventions: Diagnostic Test: Diaphragmatic ultrasound Sponsors: Hospital de Clinicas de Porto Alegre Recruiting Conditions: Weaning Mechanical Ventilation; ICU Ill Patients;...

Occupational Therapy Approach in ARX-Related Epilepsy

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Drug-Resistant Epilepsy; ARX-Related Epilepsy Interventions: Behavioral: Occupational Therapy; Other: Medikal Ketogenic Diet Therapy Sponsors: Uskudar University Completed Conditions: Drug-Resistant Epilepsy; ARX-Related Epilepsy Interventions:...

Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Sarcoma Interventions: Drug: Biological/Vaccine: hBRCA84D CAR T cells Sponsors: University College, London Recruiting Conditions: Sarcoma Interventions: Drug: Biological/Vaccine: hBRCA84D CAR T cells Sponsors: University College, London...

Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Inflammatory Bowel Disease, Ulcerative Colitis Type; Functional Disorder of Gastrointestinal Tract Interventions: Dietary Supplement: Food Supplement Colipral in film-coated tablets containing Escherichia coli 5C LMG S-33222; Other: Placebo Sponsors:...

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Obesity; Overweight Interventions: Drug: ABBV-295; Drug: Placebo Sponsors: AbbVie Not yet recruiting Conditions: Obesity; Overweight Interventions: Drug: ABBV-295; Drug: Placebo Sponsors: AbbVie Not yet...

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

by palligoelme@gmail.com | Aug 7, 2026 | Clinical Trials

​ Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy Interventions: Drug: linsitinib; Drug: Placebo Sponsors: Sling Therapeutics, Inc. Recruiting Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy Interventions: Drug: linsitinib; Drug: Placebo Sponsors:...